{
  "docId": "019de071-4e1f-74a8-b040-3577ed32c01f",
  "docSlug": "716a1960d23114ac9a8076dbc94bca80",
  "documentTitle": "Tenaya Therapeutics | IPO Presentation Deck | 36 slides",
  "authorId": "tenaya-therapeutics",
  "authorName": "Tenaya Therapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2021-07-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7843866,
  "pageNumber": 13,
  "pageCount": 36,
  "prevPage": 12,
  "nextPage": 14,
  "slideType": "solution",
  "function": "present_solution",
  "density": "overcrowded",
  "nDataPoints": 1,
  "notes": "The slide uses a split-screen layout to contrast the disease state (pathophysiology) with the therapeutic intervention (product concept).",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-4e1f-74a8-b040-3577ed32c01f/13",
  "deckHref": "/decks/019de071-4e1f-74a8-b040-3577ed32c01f",
  "deckJsonHref": "/decks/019de071-4e1f-74a8-b040-3577ed32c01f.json",
  "deckAnchorHref": "/decks/019de071-4e1f-74a8-b040-3577ed32c01f#slide-13",
  "components": [
    {
      "bbox": {
        "h": 0.25,
        "w": 0.25,
        "x": 0.62,
        "y": 0.62
      },
      "kind": "image",
      "text": "Molecular diagram showing MYBPC3 protein interaction between thin and thick filaments.",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0db1c3b3-5260-414f-bbca-db67f52af4e1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.24,
        "x": 0.03,
        "y": 0.25
      },
      "kind": "image",
      "text": "Anatomical cross-section of a heart showing LV wall hypertrophy, fibrosis, and outflow tract obstruction.",
      "attrs": null,
      "subkind": "photo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6879d207-3dbf-46b0-b5b4-2b3a980dc653",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.22,
        "x": 0.28,
        "y": 0.52
      },
      "kind": "list",
      "text": "Disease Symptoms and Severity: Heterogeneous presentation; Heart failure, sudden cardiac death can occur in adults and children; Premature infant death in the most severe cases.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "49500270-25a4-4895-a50d-935cfbb053b0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.22,
        "x": 0.28,
        "y": 0.68
      },
      "kind": "list",
      "text": "Standard of Care: No treatments address the underlying genetic cause.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "94889809-9d27-40e0-a2c2-c024e851a3d4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.22,
        "x": 0.28,
        "y": 0.25
      },
      "kind": "list",
      "text": "Pathophysiology: Mutation in MYBPC3 disrupts contractile apparatus (sarcomere); Cardiomyocyte hypertrophy, disarray and fibrosis; Stiff heart muscle contributes to poor heart filling; Abnormal heart rhythms.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d6c9044a-bc0f-45d8-ad3b-6c23ea439cd6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.45,
        "x": 0.52,
        "y": 0.25
      },
      "kind": "table",
      "text": "Target Cell: Cardiomyocyte; Modality: AAV; Gene: MYBPC3; MOA: \"Lock and key\", replace a healthy copy of MYBPC3 in patients with loss-of-function mutations; Stage: IND enabling",
      "attrs": null,
      "subkind": "kpi",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0bf8bd93-b783-4420-a9c3-1d12317f97cd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.85,
        "x": 0.03,
        "y": 0.09
      },
      "kind": "title",
      "text": "Addressing the Leading Genetic Cause of Hypertrophic Cardiomyopathy (HCM) in Adults and Children Affecting > 115K Patients in the US Alone",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "176ab259-0c36-4fe1-9840-49b2c6097de8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.45,
        "x": 0.03,
        "y": 0.03
      },
      "kind": "title",
      "text": "MYBPC3 Gene Therapy Program",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "90b2e2a2-7f4d-458c-9c8d-3b8aa4da7686",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Problem Statement Canvas",
      "slug": "problem-statement-canvas",
      "agent": "Architect",
      "layer": "slide",
      "matchId": "d1dd1d7e-9154-442c-a565-5c1d14ed8236",
      "evidence": "Pathophysiology: Mutation in MYBPC3 disrupts contractile apparatus (sarcomere); Cardiomyocyte hypertrophy, disarray and fibrosis; Stiff heart muscle contributes to poor heart filling; Abnormal heart rhythms.",
      "confidence": 0.6
    }
  ],
  "frameworks": [
    {
      "name": "before-after-bridge",
      "slug": null,
      "matchId": "07ce31b6-6bf7-478c-bb4a-b98f41a40b9d",
      "evidence": "Contrasts the disease state (before) with the therapeutic solution (after).",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 18,
      "from": 13,
      "beatId": "bfe54e44-7b0c-4c52-9e6e-5fc899bfd36c",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Product",
      "beatSlug": "sequoia-pitch-product",
      "evidence": "The 'MYBPC3 Gene Therapy Program', 'PKP2 Gene Therapy Program', and 'HDAC6i Small Molecule Program' slides",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}